BackPolaryx Therapeutics Common Stock Overview

Polaryx Therapeutics Common Stock Long Term Debt

Latest long-term debt for PLYX: $0.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer trimmed avg / median

Loading

Polaryx Therapeutics Common Stock Long Term Debt History

Loading

Polaryx Therapeutics Common Stock vs. peers: Long Term Debt Comparison

Loading

Polaryx Therapeutics Common Stock Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Polaryx Therapeutics Common Stock (PLYX) FAQ

Polaryx Therapeutics Common Stock (PLYX) currently reports a long-term debt of $0 as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Polaryx Therapeutics Common Stock's long-term debt history and peer comparisons.

Polaryx Therapeutics Common Stock's long-term debt changed from $0 to $0 (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Polaryx Therapeutics Common Stock reported $0 in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Polaryx Therapeutics Common Stock, and consider following PLYX for alerts when major investors trade the stock.

Polaryx Therapeutics Common Stock is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLYX with unrelated industries.